Site icon Hot Paths

BioLife Solutions beats top-line and bottom-line estimates; initiates FY25 outlook

  • BioLife Solutions press release (NASDAQ:BLFS): Q4 GAAP EPS of -$0.04 beats by $0.02.
  • Revenue of $22.7M (+30.5% Y/Y) beats by $0.97M.
  • GAAP gross margin of 60% and non-GAAP adjusted gross margin of 63% for the fourth quarter.

  • GAAP net loss from continuing

Exit mobile version